1. Leinenga G, Langton C, Nisbet R, Gotz J. Ultrasound treatment of neurological diseases--current and emerging applications.
Nat Rev Neurol. 2016;12:161-174.
2. Miller DL, Smith NB, Bailey MR, Czarnota GJ, Hynynen K, Makin IR, et al. Overview of therapeutic ultrasound applications and safety considerations.
J Ultrasound Med. 2012;31:623-634.
3. Goertz DE. An overview of the influence of therapeutic ultrasound exposures on the vasculature: high intensity ultrasound and microbubble-mediated bioeffects.
Int J Hyperthermia. 2015;31:134-144.
6. Ram Z, Cohen ZR, Harnof S, Tal S, Faibel M, Nass D, et al. Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy.
Neurosurgery. 2006;59:949-955 discussion 955-956.
8. Guthkelch AN, Carter LP, Cassady JR, Hynynen KH, Iacono RP, Johnson PC, et al. Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial.
J Neurooncol. 1991;10:271-284.
9. Ghanouni P, Pauly KB, Elias WJ, Henderson J, Sheehan J, Monteith S, et al. Transcranial MRI-guided focused ultrasound: a review of the technologic and neurologic applications.
AJR Am J Roentgenol. 2015;205:150-159.
10. Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al. A pilot study of focused ultrasound thalamotomy for essential tremor.
N Engl J Med. 2013;369:640-648.
11. Lipsman N, Schwartz ML, Huang Y, Lee L, Sankar T, Chapman M, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study.
Lancet Neurol. 2013;12:462-468.
12. Elias WJ, Lipsman N, Ondo WG, Ghanouni P, Kim YG, Lee W, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor.
N Engl J Med. 2016;375:730-739.
13. Boutet A, Ranjan M, Zhong J, Germann J, Xu D, Schwartz ML, et al. Focused ultrasound thalamotomy location determines clinical benefits in patients with essential tremor.
Brain. 2018;141:3405-3414.
14. Tian Q, Wintermark M, Jeffrey Elias W, Ghanouni P, Halpern CH, Henderson JM, et al. Diffusion MRI tractography for improved transcranial MRI-guided focused ultrasound thalamotomy targeting for essential tremor.
Neuroimage Clin. 2018;19:572-580.
15. Fasano A, Llinas M, Munhoz RP, Hlasny E, Kucharczyk W, Lozano AM. MRI-guided focused ultrasound thalamotomy in non-ET tremor syndromes.
Neurology. 2017;89:771-775.
16. Zaaroor M, Sinai A, Goldsher D, Eran A, Nassar M, Schlesinger I. Magnetic resonance-guided focused ultrasound thalamotomy for tremor: a report of 30 parkinson’s disease and essential tremor cases.
J Neurosurg. 2018;128:202-210.
17. Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB, et al. Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant parkinson disease: a randomized clinical trial.
JAMA Neurol. 2017;74:1412-1418.
18. Na YC, Chang WS, Jung HH, Kweon EJ, Chang JW. Unilateral magnetic resonance-guided focused ultrasound pallidotomy for Parkinson disease.
Neurology. 2015;85:549-551.
19. Magara A, Buhler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease.
J Ther Ultrasound. 2014;2:11.
20. Jeanmonod D, Werner B, Morel A, Michels L, Zadicario E, Schiff G, et al. Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain.
Neurosurg Focus. 2012;32:E1.
21. Martin E, Jeanmonod D, Morel A, Zadicario E, Werner B. High-intensity focused ultrasound for noninvasive functional neurosurgery.
Ann Neurol. 2009;66:858-861.
22. Hurwitz TA, Honey CR, Allen J, Gosselin C, Hewko R, Martzke J, et al. Bilateral anterior capsulotomy for intractable depression.
J Neuropsychiatry Clin Neurosci. 2012;24:176-182.
23. Jung HH, Kim SJ, Roh D, Chang JG, Chang WS, Kweon EJ, et al. Bilateral thermal capsulotomy with MR-guided focused ultrasound for patients with treatment-refractory obsessive-compulsive disorder: a proof-of-concept study.
Mol Psychiatry. 2015;20:1205-1211.
24. Pardridge WM. Drug transport across the blood-brain barrier.
J Cereb Blood Flow Metab. 2012;32:1959-1972.
25. Sirsi S, Borden M. Microbubble compositions, properties and biomedical applications.
Bubble Sci Eng Technol. 2009;1:3-17.
26. McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.
Ultrasound Med Biol. 2005;31:1527-1537.
27. Hancock HA, Smith LH, Cuesta J, Durrani AK, Angstadt M, Palmeri ML, et al. Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism.
Ultrasound Med Biol. 2009;35:1722-1736.
28. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the bloodbrain barrier in rabbits.
Radiology. 2001;220:640-646.
29. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles.
Ultrasound Med Biol. 2004;30:979-989.
30. Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, Yang HW, et al. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
Radiology. 2010;255:415-425.
31. McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques.
Cancer Res. 2012;72:3652-3663.
32. Sun T, Zhang Y, Power C, Alexander PM, Sutton JT, Aryal M, et al. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
Proc Natl Acad Sci U S A. 2017;114:E10281-E10290.
33. Burgess A, Ayala-Grosso CA, Ganguly M, Jordão JF, Aubert I, Hynynen K. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier.
PLoS One. 2011;6:e27877.
34. Burgess A, Huang Y, Querbes W, Sah DW, Hynynen K. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression.
J Control Release. 2012;163:125-129.
35. Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, et al. Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound.
Nat Commun. 2018;9:2336.
37. Pan H, Zhou Y, Sieling F, Shi J, Cui J, Deng C. Sonoporation of cells for drug and gene delivery.
Conf Proc IEEE Eng Med Biol Soc. 2004;5:3531-3534.
38. Kuroki M, Hachimine K, Abe H, Shibaguchi H, Kuroki M, Maekawa S, et al. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res. 2007;27:3673-3677.
39. Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy--a review of the synergistic effects of drugs and ultrasound.
Ultrason Sonochem. 2004;11:349-363.
40. Prada F, Kalani MYS, Yagmurlu K, Norat P, Del Bene M, DiMeco F, et al. Applications of focused ultrasound in cerebrovascular diseases and brain tumors.
Neurotherapeutics. 2019;16:67-87.
41. Tyler WJ. Noninvasive neuromodulation with ultrasound? A continuum mechanics hypothesis.
Neuroscientist. 2011;17:25-36.
42. Tufail Y, Matyushov A, Baldwin N, Tauchmann ML, Georges J, Yoshihiro A, et al. Transcranial pulsed ultrasound stimulates intact brain circuits.
Neuron. 2010;66:681-694.
43. Hameroff S, Trakas M, Duffield C, Annabi E, Gerace MB, Boyle P, et al. Transcranial ultrasound (TUS) effects on mental states: a pilot study.
Brain Stimul. 2013;6:409-415.
44. Legon W, Sato TF, Opitz A, Mueller J, Barbour A, Williams A, et al. Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans.
Nat Neurosci. 2014;17:322-329.
45. Zhao L, Feng Y, Shi A, Zhang L, Guo S, Wan M. Neuroprotective effect of low-intensity pulsed ultrasound against MPP+-induced neurotoxicity in PC12 cells: Involvement of K2P channels and stretch-activated ion channels.
Ultrasound Med Biol. 2017;43:1986-1999.
46. Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.
Philos Trans R Soc Lond B Biol Sci. 2012;367:2475-2484.
47. Tyler WJ, Lani SW, Hwang GM. Ultrasonic modulation of neural circuit activity.
Curr Opin Neurobiol. 2018;50:222-231.
48. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.
N Engl J Med. 2004;351:2170-2178.
49. Daffertshofer M, Fatar M. Therapeutic ultrasound in ischemic stroke treatment: experimental evidence.
Eur J Ultrasound. 2002;16:121-130.
50. Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies.
Stroke. 2010;41:280-287.
51. Saqqur M, Tsivgoulis G, Nicoli F, Skoloudik D, Sharma VK, Larrue V, et al. The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies.
J Neuroimaging. 2014;24:209-220.
52. Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase ii clinical trial.
Stroke. 2005;36:1441-1446.
53. Zafar A, Quadri SA, Farooqui M, Ortega-Gutiérrez S, Hariri OR, Zulfiqar M, et al. MRI-guided high-intensity focused ultrasound as an emerging therapy for stroke: a review.
J Neuroimaging. 2019;29:5-13.
54. Schellinger PD, Alexandrov AV, Barreto AD, Demchuk AM, Tsivgoulis G, Kohrmann M, et al. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
Int J Stroke. 2015;10:1141-1148.
55. Alexandrov AV, Köhrmann M, Soinne L, Tsivgoulis G, Barreto AD, Demchuk AM, et al. Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
Lancet Neurol. 2019;18:338-347.
56. Molina CA, Barreto AD, Tsivgoulis G, Sierzenski P, Malkoff MD, Rubiera M, et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial.
Ann Neurol. 2009;66:28-38.
57. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.
Stroke. 2006;37:425-429.
58. Alexandrov AV, Mikulik R, Ribo M, Sharma VK, Lao AY, Tsivgoulis G, et al. A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke.
Stroke. 2008;39:1464-1469.
59. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke. 2018;49:e46-e110.
60. Ilyas A, Chen CJ, Ding D, Romeo A, Buell TJ, Wang TR, et al. Magnetic resonance-guided, high-intensity focused ultrasound sonolysis: potential applications for stroke.
Neurosurg Focus. 2018;44:E12.
61. Mu HM, Wang LY. Effect of therapeutic ultrasound on brain angiogenesis following intracerebral hemorrhage in rats.
Microvasc Res. 2015;102:11-18.
62. Lu ZY, Li RL, Zhou HS, Huang JJ, Qi J, Su ZX, et al. Rescue of hypertension-related impairment of angiogenesis by therapeutic ultrasound.
Am J Transl Res. 2016;8:3087-3096.
63. Jiang X, Savchenko O, Li Y, Qi S, Yang T, Zhang W, et al. A review of low-intensity pulsed ultrasound for therapeutic applications.
IEEE Trans Biomed Eng. 2018 Dec 25;[Epub].
https://doi.org/10.1109/TBME.2018.2889669.
64. Kobayashi Y, Sakai D, Iwashina T, Iwabuchi S, Mochida J. Low-intensity pulsed ultrasound stimulates cell proliferation, proteoglycan synthesis and expression of growth factor-related genes in human nucleus pulposus cell line.
Eur Cell Mater. 2009;17:15-22.
65. Iwabuchi S, Ito M, Hata J, Chikanishi T, Azuma Y, Haro H. In vitro evaluation of low-intensity pulsed ultrasound in herniated disc resorption.
Biomaterials. 2005;26:7104-7114.
66. Sayilir S. The short-term effects of TENS plus therapeutic ultrasound combinations in chronic neck pain.
Complement Ther Clin Pract. 2018;31:278-281.
67. Metin Ökmen B, Ökmen K, Altan L. Investigation of the effectiveness of therapeutic ultrasound with high-resolution ultrasonographic cross-sectional area measurement of cervical nerve roots in patients with chronic cervical radiculopathy: a prospective, controlled, single-blind study.
J Med Ultrason (2001). 2018;45:479-486.
68. Walling I, Panse D, Gee L, Maietta T, Kaszuba B, Kumar V, et al. The use of focused ultrasound for the treatment of cutaneous allodynia associated with chronic migraine.
Brain Res. 2018;1699:135-141.